Skip to content
Disclosery

EXANE DERIVATIVES: NKE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on NKE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,264 NKE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,264 shares
    Change vs previous 13F -3,975 shares

    0.13% of the 13F portfolio, value $231,355.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 6,239 shares
    Change vs previous 13F +589 shares

    0.24% of the 13F portfolio, value $839,526.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 5,650 shares
    Change vs previous 13F -1,187 shares

    0.23% of the 13F portfolio, value $941,716.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 6,837 shares
    Change vs previous 13F -4,560 shares

    0.25% of the 13F portfolio, value $992,977.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 11,397 shares
    Change vs previous 13F +6,778 shares

    0.43% of the 13F portfolio, value $1,841,682.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 4,619 shares
    Change vs previous 13F +621 shares

    0.18% of the 13F portfolio, value $613,847.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 3,998 shares
    Change vs previous 13F +2,951 shares

    0.17% of the 13F portfolio, value $565,622.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,047 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $131,444.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).